The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs in the form of grants and investments to bring game-changing innovations to the market.
The second EIC 2023 call closed on March 22, 2023, when a new set of companies were awarded by the European Innovation Council to receive funding. Results have been recently published:
- 51 companies have been funded by the EIC in the March 2023 call (an increase by 59% compared to the previous call) with a total budget of €261M (33% increase in budget),
- The selected companies spread across 17 countries, but the top three countries in this call have been the Netherlands (14%), France (12%), Israel and UK (9% each).
- Blended Finance has been the most awarded financing type (45%).
551 proposals were submitted for this call (an increase by 15%), and 139 reached the interview stage (25% success rate). Although this call has not been as competitive as the January call, the selected companies have gone through a challenging and competitive process where only 51 of them (32% success rate at Step 3) have been awarded (19 more companies compared to the previous one, that is, an increase by 12% in success rates).
Almost 30% percent of the winners (15 of the 51 companies) have a female CEO, CTO (Chief Technology Officer) or CSO (Chief Scientific Officer).
More companies have been funded through this call which also represents an increase in budget: this time, the total awarded funding amounts to €261 million in a combination of grants and equity investments, which will be paid through the EIC Fund.
The geographical focus of the winners spreads across 17 countries, including three widening countries, being Netherlands (14%), France (12%), Israel and UK (9% each) the countries on the top of the chart:

Figure 1. Number of EIC winners per country
Most awarded projects belong to blended finance (23 out of 51 proposals, 45%), followed by grant first (22 out of 51 applications, 43%) and, finally, grant only (6 out of 51 proposals, 12%).

Figure 2. Share of winning projects by financing type
The 51 awarded projects can be classified into three categories: New deep-tech technologies & ICT; Health & Medical care; and Environment. Health has been the most awarded area with 27 out of 51 projects (52.94%), followed by new deep-tech technologies and ICT (17 out of 51 projects, 33.33%), and, finally, environment (7 out of 51, 13.72%).

Figure 3. Share of winning projects by innovation area.
The table below includes the full list of winners, including our friends from ENERPOLY, the Swedish startup disrupting the battery market through its unique and environmentally friendly zinc-ion battery cells and packs for stationary storage. Congratulations to all winners!
Company Name | Proposal Acronym | Short Description | Recommended Financing Type | Website | Country |
ContextflowGMBH | Scaling generation AI chest CT | Integrated AI-based Clinical Decision Support for Radiologists | Blended finance | https://contextflow.com/ | Austria |
Arcsec NV | DeDUST | Debris Detection Using Star Trackers | Grant only | https://www.arcsec.space/ | Belgium |
Convert Pharmaceuticals S.A | TUMAGNOSTIC | A disruptive hypoxia activated prodrug for the treatment of resistant cancers: an AI-driven approach | Blended finance | www.convertpharma.com | Belgium |
Rehaler ApS | PAREMA | PArtial REbreathing for Migraine with Aura | Grant first | www.rehaler.com | Denmark |
SUBRA A/S | SUBRACABLE | Making Superconducting power grids a feasible solution for Europe | Grant first | https://www.subra.dk/ | Denmark |
Better Medicine OÜ | BMAI | Empowering Radiologists in Cancer Diagnostics with Artificial Intelligence | Grant first | https://www.bettermedicine.ai/ | Estonia |
GeneCode AS | KevadBio | Developing a novel Parkinson’s disease drug using small molecule mimetics of Glial cell line-Derived Neurotrophic Factor (GDNF) | Grant first | https://genecode.com/ | Estonia |
Ligneasy Oy | LignEasy | Worlds first sulfuric acid-free kraft lignin recovery system | Grant first | https://www.ligneasy.fi/ | Finland |
Cephalgo | ADAPTE | A novel and accurate emotion recognition system for real-time and continuous patient monitoring in psychiatry | Grant first | https://cephalgo.com/language/en/ | France |
DIOGENX SAS | DiogenX | Beta-cell recovery to counter diabetes | Blended finance | https://diogenx.com/ | France |
Giskard AI (SAS) | Giskard | Quality Assurance for AI | Grant first | https://www.giskard.ai/ | France |
GREENERWAVE | Greenerwave | The first high-performance, low-cost flat panel antenna terminal at Ka band to unlock the full potential of satellite-based broadband communications | Blended finance | www.greenerwave.com | France |
PLENESYS | hyplasma | A clean and cost competitive hydrogen production solution near the end user thanks to an innovative plasma methane pyrolysis technology | Blended finance | www.plenesys.com | France |
Panntherapi | PANNEXIN | Pannexin 1 – a novel target for pediatric orphan epilepsy | Grant first | https://panntherapi.com/ | France |
Cellbox-Solutions GmbH | CELLBOX | Innovative transport of “in culture” cell-based materials ensuring product safety, quality and function | Blended finance | https://cellbox-solutions.com/ | Germany |
LUBIS EDA GmbH | OverSemi | Optimisation of a novel software tool for automation of the design & verification process of semiconductor development | Grant first | https://lubis-eda.com/ | Germany |
Angiolutions GmbH | STAAART SmarT Abdominal Aortic AneuRysm Treatment | World’s first device-based treatment for small abdominal aortic aneurysms based on revolutionary new treatment paradigm | Grant first | https://angiolutions.com | Germany |
Twinsity GmbH | Twinspect | First fast and automated (<5 min) AI-based inspection to increase operational safety of large critical infrastructure, e.g., bridges, dams, and oil & gas platforms and refineries | Blended finance | https://twinsity.com/ | Germany |
BIOSIMULYTICS LIMITED | biosim m2m | BioSim M2M: Molecules to Medicine | Grant first | https://www.biosimulytics.ai/?hsLang=en | Ireland |
Celtic Biotech Ltd | CB24 | Development of a natural therapeutic treatment for late-stage lung cancer patients | Grant first | https://celticbiotech.com/ | Ireland |
Luminate Medical Limited | LILY | LILY: A Breakthrough Technology to Prevent Chemotherapy-Induced Hair Loss | Blended finance | https://www.luminatemed.com/ | Ireland |
Hooke Bio Ltd | MEra – Micro Era | Mera – Ethical, accurate drug development | Blended finance | www.hookebio.com | Ireland |
Escala Medical LTD | apyx | The first non-surgical repair for Pelvic Organ Prolapse | Blended finance | http://www.escalamedical.com/ | Israel |
Butterfly Medical Ltd. | MPRD | Innovative, minimally invasive Medical Prostatic Retraction Device for the treatment of Benign Prostatic Hyperplasia (BPH) Patients in the office settings. | Blended finance | https://butterfly-medical.com/ | Israel |
NeuReality LTD | NR1 | AI-centric Server on Chip for increasing complexity and scale of AI inference applications, enabling the scale of real-life AI applications | Blended finance | https://www.neureality.ai/ | Israel |
BIOPROTECT LTD | ProSpace | BioProtect Balloon Implant System – Enabling Safe Prostate Radiation Treatment even at extreme dosage | Blended finance | https://www.bioprotect.com/ | Israel |
X-trodes Ltd | S-trodes | Reliable Medical Grade Home-Based Test for Self-Use for people with Sleep DIsorders | Blended finance | https://xtrodes.com/ | Israel |
Finapp srl | finapp cosmic ray neutron sensing | Scaling up the FINAPP Cosmic Ray Neutron Sensing probe | Grant first | https://www.finapptech.com/ | Italy |
HPCC System srl | NbyN | The New Generation Needle by Needle Knitting Machine | Grant first | http://www.hpccsystem.com/ | Italy |
MORPHOTONICS BV | AR-R2P | Mass Manufacturing Augmented Reality (AR) Waveguides via Roll-to-Plate Nanoimprinting | Grant first | https://www.morphotonics.com/ | Netherlands |
Stentit B.V | EX-STENT | THE NEXT STENT GENERATION: A FIRST-IN-CLASS REGENERATIVE NANOFIBER STENT TO RECONSTRUCT ARTERIES FROM THE INSIDE OUT | Blended finance | https://www.stentit.com/ | Netherlands |
ORANGE QUANTUM SYSTEMS OPERATIONAL BV | HTQC-Diagnostics | High-Throughput Quantum Chip Diagnostics | Grant first | https://orangeqs.com/ | Netherlands |
Genewity B.V. | i-THYMUS | The i-Thymus: wielding the potential of gene therapy, cell therapy and induced pluripotent stem cells for the regeneration of the thymus and the adaptive immune system | Grant first | http//:www.genewity.tech | Netherlands |
THIRONA BV | LungQ-Care | Facilitating personalised Lung Treatment Decisions through a Deeptech AI Clinical Decision Support System | Grant first | https://thirona.eu/ | Netherlands |
Magneto B.V. | Magnetocaloric heating and cooling | Disrupting the cooling and heating industry: a revolutionary green, energy efficient and cost competitive magnetocaloric technology platform | Grant first | https://magneto.systems/ | Netherlands |
Mu-G Knowledge Management BV | PATS | PATS: Eliminating pesticides! | Blended finance | www.pats-drones.com | Netherlands |
PAMGENE INTERNATIONAL BV | ROUTINE | canceR agnOstic immUnoTherapy predIctioN blood-tEst | Blended finance | https://pamgene.com/ | Netherlands |
Excess Engineering AS | Electric Actuator (The missing link) | Electrification of heavy machinery | Blended finance | www.excessengineering.no | Norway |
PICTERUS AS | Picterus Jaundice mHealth platform | Bringing newborn care home: An integral mHealth solution for neonatal jaundice management | Grant first | https://www.picterus.com/ | Norway |
SGPR.TECH SPLOKA Z OGRANICZONA ODPOWIEDZIALNOSCIA | WIDMO Cities | Providing complete subsurface information of the urban areas | Blended finance | www.widmo.tech | Poland |
Hydrumedical, S.A | HYDRUSTENT | Hydrogel Biodegradable Ureteral Stent | Blended finance | www.hydrumedical.pt | Portugal |
Oils4cure S.L. | oils4cure | Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous Sclerosis | Grant first | https://oils4cure.com/home/ | Spain |
MiMARK Diagnostics, S.L | WomEC | Reshaping women’s health through the understanding of gynecological fluids. WomEC: Antibody-based IVD test based on 5 novel protein biomarkers quantified in liquid biopsy | Grant first | https://www.mimark.es/ | Spain |
ENERPOLY AB | EUROZIP | EUROZIP: European Zinc-Ion Plant | Blended finance | www.enerpoly.com | Sweden |
NEOGAP Therapeutics AB | NEOpTTL | Innovative approach to an Individualised T-Cell Immunotherapy for cancer, using Personalised Tumour Trained Lymphocytes (pTTL) that is reliable, cost-effective, scalable and easy to implement | Blended finance | www.neogap.se | Sweden |
Molecular Attraction AB | SemioMVC | Mosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector control | Blended finance | https://www.molecular-attraction.com | Sweden |
Lumi Space Ltd | Lumi SLR | Revolutionising space sustainability through precise and scalable Satellite Laser Ranging | Grant only | https://www.lumi.space/ | United Kingdom |
CRYPTO QUANTIQUE LIMITED | QRYPTON | Quantum secuRe crYptograPhy to secure IoT devices in deep submicrOn Nodes | Grant only | https://www.cryptoquantique.com/ | United Kingdom |
Newrotex Limited | The Oxford Nerve Conduit | A breakthrough silk-based solution for treatment of peripheral nerve injury | Grant only | https://www.newrotex.com/ | United Kingdom |
Wave Photonics Ltd. | Wave Photonics | The platform to unleash the transformative potential of integrated photonics | Grant only | https://www.wavephotonics.com/ | United Kingdom |
Zero Point Motion Ltd | ZPM IMU | ZERO POINT MOTION LTD | Grant only | https://zeropointmotion.com | United Kingdom |